Recerca
Farmacologia Clínica
Factor d'impacte: mitjana: 3.5, total: 101.59
Articles de l'any 2010
Original
-
Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial
Lozano LK, Tovar JL, Sampol G, Romero O, Jurado MJ, Segarra A, Espinel E, Rios J, Untoria MD, Lloberes P
J HYPERTENS. 2010; 8: 2161-2168. IF: 4.988 -
Substitution of raltegravir for ritonavir-boosted protease inhibitors in HIV-infected patients: the SPIRAL study
Martinez E, Larrousse M, Llibre JM, Gutierrez F, Saumoy M, Antela A, Knobel H, Murillas J, Berenguer J, Pich J, Perez I, Gatell JM
AIDS. 2010; 24: 1697-1707. IF: 4.909 -
Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis
Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valenti M, Vieta E
INT J NEUROPSYCHOPH. 2010; 13: 5-14. IF: 4.874 -
Circumferential pulmonary vein ablation: Does use of a circular mapping catheter improve results? A prospective randomized study
Tamborero D, Mont L, Berruezo A, Guasch E, Rios J, Nadal M, Matiello M, Andreu D, Sitges M, Brugada J
HEART RHYTHM . 2010; 7: 612-618. IF: 4.559 -
Soluble fibre (Plantago ovata husk) reduces plasma low-density lipoprotein (LDL) cholesterol, triglycerides, insulin, oxidised LDL and systolic blood pressure in hypercholesterolaemic patients: A randomised trial
Sola R, Bruckert E, Valls RM, Narejos S, Luque X, Castro-Cabezas M, Domenech G, Torres F, Heras M, Farres X, Vaquer JV, Martinez JM, Almaraz MC, Anguera A
ATHEROSCLEROSIS. 2010; 211: 630-637. IF: 4.522 -
Genetically-Defined Deficiency of Mannose-Binding Lectin Is Associated with Protection after Experimental Stroke in Mice and Outcome in Human Stroke
Cervera A, Planas AM, Justicia C, Urra X, Jensenius JC, Torres F, Lozano F, Chamorro A
PLoS ONE. 2010; 5: 0-0. IF: 4.351 -
Expression of the neuron-specific protein CHD5 is an independent marker of outcome in neuroblastoma
Garcia I, Mayol G, Rodriguez E, Sunol M, Gershon TR, Rios J, Cheung NKV, Kieran MW, George RE, Perez-Atayde AR, Casala C, Galvan P, DeTorres C, Mora J, Lavarino C
MOL CANCER. 2010; 9: 0-0. IF: 4.16 -
Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI (R)
Vilaplana C, Montane E, Pinto S, Barriocanal AM, Domenech G, Torres F, Cardona PJ, Costa J
VACCINE. 2010; 28: 1106-1116. IF: 3.616 -
Obstructive sleep apnoea and 24-h blood pressure in patients with resistant hypertension
Lloberes P, Lozano L, Sampol G, Romero O, Jurado MJ, Rios J, Untoria MD, Tovar JL
J SLEEP RES. 2010; 19: 597-602. IF: 3.5 -
New interventions to increase influenza vaccination rates in health care workers
Llupia A, Garcia-Basteiro AL, Olive V, Costas L, Rios J, Quesada S, Varela P, Bayas JM, Trilla A
AM J INFECT CONTROL. 2010; 38: 476-481. IF: 3.013 -
Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration
Guevara M, Baccaro ME, Rios J, Martin-Llah M, Uriz J, DelArbol LR, Planas R, Monescillo A, Guarner C, Crespo J, Banares R, Arroyo V, Gines P
LIVER INT. 2010; 30: 1137-1142. IF: 2.987 -
Monitoring in resuscitation: Comparison of cardiac output measurement between pulmonary artery catheter and NICO
Carretero M, Fontanals J, Agusti M, Arguis M, Martinez-Ocon J, Ruiz A, Rios J
RESUSCITATION. 2010; 81: 404-409. IF: 2.712 -
Are Sodium Transporters in Urinary Exosomes Reliable Markers of Tubular Sodium Reabsorption in Hypertensive Patients?
Esteva-Font C, Wang XY, Ars E, Guillen-Gomez E, Sans L, Saavedra IG, Torres F, Torra R, Masilamani S, Ballarin JA, Fernandez-Llama P
NEPHRON PHYSIOL. 2010; 114: 0-0. IF: 2.528 -
Pressure Inside the Neuroendoscope: Correlation With Epidural Intracranial Pressure During Neuroendoscopic Procedures
Salvador L, Valero R, Carazo J, Caral L, Rios J, Carrero E, Tercero J, DeRiva N, Hurtado P, Ferrer E, Fabregas N
J NEUROSURG ANESTH. 2010; 22: 240-246. IF: 2.412 -
Predictors of mortality in chest wall disease treated with noninvasive home mechanical ventilation
Marti S, Pallero M, Ferrer J, Rios J, Rodriguez E, Morell F, Munoz X
RESP MED. 2010; 104: 1843-1849. IF: 2.331 -
Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV Type 1-Infected Patients Using a Nonnucleoside Reverse Transcriptase Inhibitor-Based or a Boosted Protease Inhibitor-Based Antiretroviral Regimen: Three-Year Results
Miro JM, Manzardo C, Pich J, Domingo P, Ferrer E, Arribas JR, Ribera E, Arrizabalaga J, Lonca M, Cruceta A, DeLazzari E, Fuster M, Podzamczer D, Plana M, Gatell JM
AIDS RES HUM RETROV. 2010; 26: 747-757. IF: 2.178 -
Association of Admission Plasma D-Dimer Concentration with Diagnosis and Outcome in Horses with Colic
Cesarini C, Monreal L, Armengou L, Delgado MA, Rios J, Jose-Cunilleras E
J VET INTERN MED. 2010; 24: 1490-1497. IF: 2.168 -
Low-Molecular-Weight Heparin Dosage in Newborn Foals
Armengou L, Monreal L, Delgado MA, Rios J, Cesarini C, Jose-Cunilleras E
J VET INTERN MED. 2010; 24: 1190-1195. IF: 2.168 -
Heterogeneity prevails: the state of clinical trial data management in Europe - results of a survey of ECRIN centres
Kuchinke W, Ohmann C, Yang Q, Salas N, Lauritsen J, Gueyffier F, Leizorovicz A, Schade-Brittinger C, Wittenberg M, Voko Z, Gaynor S, Cooney M, Doran P, Maggioni A, Lorimer A, Torres F, Mcpherson G, Charwill J, Hellstrom M, Lejeune S
TRIALS. 2010; 11: 0-0. IF: 2.02 -
Liver Stiffness Identifies Two Different Patterns of Fibrosis Progression in Patients with Hepatitis C Virus Recurrence After Liver Transplantation
Carrion JA, Torres F, Crespo G, Miquel R, Garcia-Valdecasas JC, Navasa M, Forns X
HEPATOLOGY. 2010; 51: 23-34. IF: 10.84 -
High-Flow Oxygen Therapy in Acute Respiratory Failure
Roca O, Riera J, Torres F, Masclans JR
RESP CARE. 2010; 55: 408-413. IF: 1.524 -
Analysis of the Clinical Score Progressions During the First Year After First MTPJ Fusion
Poggio D, DeRetana PF, Borda D, Hortua P, Asuncion J, Rios J
FOOT ANKLE INT. 2010; 31: 578-583. IF: 1.101 -
Comparative bioavailability study of triflusal oral solution vs. triflusal capsules in healthy subjects A single, randomized, two-way cross-over, open-label phase I study
Izquierdo I, Borja J, Rovira S, Pelagio P, Torres F, Cebrecos J, Garcia-Rafanell J
ARZNEIMITTEL-FORSCH. 2010; 60: 36-41. IF: 0.691
Multicèntrics
-
Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study
Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, DeWit S, Law M, Monforte AD, Friis-Moller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J
J INFECT DIS. 2010; 201: 318-330. IF: 5.865 -
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D study The Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group
Smith C, Sabin CA, Lundgren JD, Thiebaut R, Weber R, Law M, Monforte AD, Kirk O, Friis-Moller N, Phillips A, Reiss P, El-Sadr W, Pradier C, Worm SW
AIDS. 2010; 24: 1537-1548. IF: 4.909 -
High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome
Worm SW, Friis-Moller N, Bruyand M, Monforte AD, Rickenbach M, Reiss P, El-Sadr W, Phillips A, Lundgren J, Sabin C
AIDS. 2010; 24: 427-435. IF: 4.909 -
HBV or HCV coinfections and risk of myocardial infarction in HIV-infected individuals: the D:A:D Cohort Study
Weber R, Sabin C, Reiss P, DeWit S, Worm SW, Law M, Dabis F, Monforte AD, Fontas E, El-Sadr W, Kirk O, Rickenbach M, Phillips A, Ledergerber B, Lundgren J
ANTIVIR THER. 2010; 15: 1077-1086. IF: 4.322 -
Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study
Friis-Moller N, Thiebaut R, Reiss P, Weber R, Monforte AD, DeWit S, El-Sadr W, Fontas E, Worm S, Kirk O, Phillips A, Sabin CA, Lundgren JD, Law MG
EUR J CARDIOV PREV R. 2010; 17: 491-501. IF: 2.511